← Back to the brief
istitlaa (ISTITL) · Public Consultation

Saudi Food and Drug Authority: Good Clinical Practice (GCP): Special Considerations for Advanced Therapy Medicinal Products (ATMPs)

الهيئة العامة للغذاء والدواء: أسس الممارسة السريرية الجيدة: الاعتبارات الخاصة للعلاجات المتقدمة

Action required (deferred)Reference

The guideline provides additional requirements for the conduct, monitoring, and oversight of clinical trials involving Advanced Therapy Medicinal Products (ATMPs).

PublishedAugust 13, 2026
Consultation closesSeptember 13, 2026
GazetteNot gazetted
Original PDF ↗

See all from ISTITL →

Saudi regulatory updates, in one morning brief

Bawadir tracks what Saudi regulators issue and delivers what needs your attention each working morning. Your email is all we ask for.

Check out the checklists →

Free. One click to unsubscribe, any time.